Geneva Capital Management LLC Repligen Corp Transaction History

Geneva Capital Management LLC

$5.85 Billion
Q2 2025

A detailed history of Geneva Capital Management LLC transactions in Repligen Corp stock. As of the latest transaction made, Geneva Capital Management LLC holds 487,534 shares of RGEN stock, worth $59.2 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

487,534

Previous 143,543 239.64%

Holding current value

$59.2 Million

Previous $18.3 Million 232.01%

% of portfolio

1.04%

Previous 0.35%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	BUY	$108.89 - $145.23 $37.5 Million - $50 Million	343,991 Added 239.64%	487,534 $60.6 Million
Q1 2025 May 09, 2025	BUY	$127.24 - $174.24 $1.01 Million - $1.39 Million	7,958 Added 5.87%	143,543 $18.3 Million
Q4 2024 Feb 06, 2025	SELL	$123.41 - $160.92 $381,583 - $497,564	-3,092 Reduced 2.23%	135,585 $19.5 Million
Q3 2024 Nov 05, 2024	BUY	$119.79 - $167.35 $1.31 Million - $1.83 Million	10,908 Added 8.54%	138,677 $20.6 Million
Q2 2024 Aug 14, 2024	BUY	$120.0 - $182.95 $1.09 Million - $1.66 Million	9,051 Added 7.62%	127,769 $16.1 Million
Q1 2024 May 03, 2024	SELL	$170.78 - $208.42 $247,460 - $302,000	-1,449 Reduced 1.21%	118,718 $21.8 Million
Q4 2023 Feb 06, 2024	BUY	$114.17 - $185.35 $247,063 - $401,097	2,164 Added 1.83%	120,167 $21.6 Million
Q3 2023 Nov 13, 2023	SELL	$138.78 - $176.51 $777,584 - $988,985	-5,603 Reduced 4.53%	118,003 $18.8 Million
Q2 2023 Aug 01, 2023	SELL	$138.42 - $180.31 $906,235 - $1.18 Million	-6,547 Reduced 5.03%	123,606 $17.5 Million
Q1 2023 May 12, 2023	BUY	$154.26 - $198.1 $167,834 - $215,532	1,088 Added 0.84%	130,153 $21.9 Million
Q4 2022 Feb 07, 2023	SELL	$162.42 - $220.56 $2.01 Million - $2.72 Million	-12,348 Reduced 8.73%	129,065 $21.9 Million
Q3 2022 Nov 02, 2022	SELL	$160.42 - $256.21 $320,198 - $511,395	-1,996 Reduced 1.39%	141,413 $26.5 Million
Q2 2022 Aug 02, 2022	SELL	$140.68 - $188.02 $29,542 - $39,484	-210 Reduced 0.15%	143,409 $23.3 Million
Q1 2022 May 02, 2022	BUY	$161.19 - $257.96 $3 Million - $4.79 Million	18,582 Added 14.86%	143,619 $27 Million
Q4 2021 Feb 02, 2022	BUY	$247.59 - $304.47 $1.83 Million - $2.25 Million	7,404 Added 6.29%	125,037 $33.1 Million
Q3 2021 Nov 08, 2021	SELL	$194.77 - $324.21 $1.15 Million - $1.92 Million	-5,915 Reduced 4.79%	117,633 $34 Million
Q2 2021 Aug 11, 2021	SELL	$165.87 - $220.95 $730,491 - $973,063	-4,404 Reduced 3.44%	123,548 $24.7 Million
Q1 2021 May 03, 2021	SELL	$180.37 - $226.26 $5.4 Million - $6.78 Million	-29,949 Reduced 18.97%	127,952 $24.9 Million
Q4 2020 Feb 02, 2021	SELL	$148.08 - $206.57 $2.79 Million - $3.89 Million	-18,822 Reduced 10.65%	157,901 $30.3 Million
Q3 2020 Nov 12, 2020	BUY	$122.51 - $158.27 $1.79 Million - $2.31 Million	14,619 Added 9.02%	176,723 $26.1 Million
Q2 2020 Aug 13, 2020	BUY	$94.33 - $140.48 $7.41 Million - $11 Million	78,502 Added 93.9%	162,104 $20 Million
Q1 2020 May 15, 2020	BUY	$84.96 - $109.14 $7.1 Million - $9.12 Million	83,602 New	83,602 $8.07 Million

Others Institutions Holding RGEN

# of Institutions

502

Shares Held

58.2M

Call Options Held

89.3K

Put Options Held

679K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.74B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneva Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geneva Capital Management LLC with notifications on news.

Account

Geneva Capital Management LLC Repligen Corp Transaction History